Skip to content

Combining disease and prescription with syndrome in ischemic stroke - a randomized, controlled, parallel-group, blinded multicenter clinical study

Combining disease and prescription with syndrome in ischemic stroke - a randomized, controlled, parallel-group, blinded multicenter clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003919
Enrollment
Unknown
Registered
2013-10-11
Start date
2013-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic stroke

Interventions

Experimental group:Taking Chinese traditional medicine prescription based on syndrome differentiation
Control group:Taking Danshen, Honghua

Sponsors

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) diagnosis of cerebral infarction; 2) diagnosis of Fengtan Zuluo zheng, Tanre Fushi zheng, Qixu Xueyu zheng, or Yinxu Fengdong zheng; 3) onset within 72 hours and NIHSS score with 5-22; 4) 35~80 years old; 5) should signe for the informed consent.

Exclusion criteria

Exclusion criteria: 1) with thrombolysis therapy; 2) with disturbance of consciousness; 3) stroke caused by brain tumor, traumatic brain injury, blood disease; 4) mental disorder or severe dementia; 5) with stroke history and the sequala will affect research; 6) with severe aphasia that will affects collection of information; 7) with severe infection and upper gastrointestinal bleeding.

Design outcomes

Primary

MeasureTime frame
Modified Rankin Scale;Barthel;NIHSS;PRO;Stroke syndrome factor evaluation scal;

Secondary

MeasureTime frame
The compliance of TCM syndrome differentiation and;

Countries

China

Contacts

Public ContactGao Ying

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine

gaoying973@126.com+86 10 84013209

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026